EDN1 and glioblastoma: A unique role for ECE-1 has also been proposed by Berger et al (2005) who demonstrated that ECE-1 inhibitors could inhibit proliferation of human glioblastoma cells without reducing ET-1 levels (Berger et al, 2005).